Teruhito Takakuwa¹, Ryosuke Yamamura¹, Kensuke Ohta², Hitomi Kaneko³, Kazunori Imada³, Aya Nakaya⁴, Shinichi Fuchida⁵, Hirohiko Shibayama⁶, Mitsuhiro Matsuda⁷, Yutaka Shimazu⁸, Yoko Adachi⁹, Satoru Kosugi¹⁰, Hitoji Uchiyama¹¹, Hirokazu Tanaka¹², Hitoshi Hanamoto¹³, Yuji Shimura¹⁴, Junya Kanda¹⁵, Yoshiyuki Onda¹⁵, Nobuhiko Uoshima¹⁶, Hideo Yagi¹⁷, Satoshi Yoshihara¹⁸, Masayuki Hino¹⁹, Chihiro Shimazaki⁵, Akifumi Takaori¹⁵, Junya Kuroda¹⁴, Itaru Matsumura¹², Yuzuru Kanakura⁶, Shosaku Nomura⁴ (1.Department of Hematology, Osaka Saiseikai Nakatsu Hospital, 2.Hematology Ohta Clinic, Shinsaibashi, 3.Department of Hematology, Japanese Red Cross Osaka Hospital, 4.Hematol., Kansai Medical University Medical Center, 5.Hematol., Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, 6.Hematol. and Oncol., Osaka University Graduate School of Medicine, 7.Department of Hematology, PL General Hospital, 8.Hematol., Japanese Red Cross Wakayama Medical Center, 9.Department of Internal Medicine, JCHO Kobe Central Hospital, 10.Department of Internal Medicine (Hematology), Toyonaka Municipal Hospital, 11.Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, 12.Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, 13.Department of Hematology, Kindai University Nara Hospital, 14.Hematol. and Oncol., Kyoto Prefectural University of Medicine, 15.Hematol. and Oncol., Graduate School of Medicine, Kyoto University, 16.Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, 17.Hematol. and Oncol., Nara Prefecture General Medical Center, 18.Hematol., Hyogo College of Medicine, Department of Internal Medicine, 19.Hematol., Osaka City University Graduate School of Medicine)

Kensuke Ohta^1,2, Mitsuo Hori³, Hiroshi Handa⁴, Gen Kinoshita⁵, Suresh Shelat⁶, Masafumi Miyoshi⁵, Naoki Takezako⁷, Kohmei Kubo⁸ (1.Department of Hematology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan, 2.Hematology Ohta Clinica, Shinsaibashi, Osaka, Japan, 3.Department of Hematology, Ibaraki Prefectural Central Hospital, Kasama, Japan, 4.Department of Hematology, Gunma University Hospital, Maebashi, Japan, 5.Bristol-Myers Squibb K.K., Tokyo, Japan, 6.Bristol-Myers Squibb, Princeton, NJ, USA, 7.National Hospital Organization Disaster Medical Center, Tokyo, Japan, 8.Department of Hematology, Aomori Prefectural Central Hospital, Aomori, Japan)

Masafumi Taniwaki¹, Kazutaka Sunami², Kenshi Suzuki³, Kazuteru Ohashi⁴, Shinsuke Iida⁵, Shinichiro Okamoto⁶, Hiroshi Handa⁷, Kosei Matsue⁸, Suresh Shelat⁹, Oumar Sy⁹, Masafumi Miyoshi¹⁰, Morio Matsumoto¹¹ (1.University Hospital Kyoto Prefectural University of Medicine, Kyoto, Japan, 2.National Hospital Organization Okayama Medical Center, Okayama, Japan, 3.Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan, 4.Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, 5.Department of Hematology, Nagoya City University Hospital, Nagoya, Japan, 6.Department of Hematology, Keio University Hospital, Tokyo, Japan, 7.Department of Hematology, Gunma University Hospital, Maebashi, Japan, 8.Department of Hematology, Kameda Medical Center, Kamogawa, Japan, 9.Bristol-Myers Squibb, Princeton, NJ, USA, 10.Bristol-Myers Squibb K.K., Tokyo, Japan, 11.National Hospital Organization Shibukawa Medical Center, Shibukawa, Japan)

Shigeki Ito¹, Mitsuo Hori², Naoki Takezako³, Kazutaka Sunami⁴, Junya Kuroda⁵, Mihaela Popamckiver⁶, Yingming Jou⁶, Suresh Shelat⁶, Masafumi Miyoshi⁷, Kenshi Suzuki⁸ (1.Department of Clinical Oncology, Iwate Medical University Hospital, 2.Department of Hematology, Ibaraki Prefectural Central Hospital, Kasama, Japan, 3.National Hospital Organization Disaster Medical Center, Tokyo, Japan, 4.National Hospital Organization Okayama Medical Center, Okayama, Japan, 5.Div. Hematol. Oncol., Kyoto Prefectural University of Medicine, Kyoto, Japan, 6.Bristol-Myers Squibb, Princeton, NJ, USA, 7.Bristol-Myers Squibb K.K., Tokyo, Japan, 8.Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan)

Yukako Hattori^1,2, Ayumi Numata², Reina Watanabe², Tomonori Nakazato³, Hirotaka Takasaki², Yoshimi Ishii⁴, Kumiko Kishimoto^4,5, Taiki Ando⁴, Maki Hagihara⁴, Satomi Ito⁵, Hiroyuki Takahashi², Kazuho Miyashita⁴, Satoshi Koyama⁶, Hiroyuki Fujita⁵, Rika Sakai², Hideaki Nakajima⁶ (1.Department of Hematology/Oncology, Yamato Municipal Hospital, Yamato, Japan, 2.Department of Hematology and Medical Oncology, Kanagawa Cancer Center, 3.Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan, 4.Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan, 5.Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan, 6.Department of Hematology and Clinical Immunology, Yokohama City University Hospital)

Makoto Sasaki¹, Tohru Izumi², Takuya Komeno³, Yasuhito Terui⁴, Takaaki Chou⁵, Takashi Ikeda⁶, Deborah Berg⁷, Shinichi Fukunaga⁸, Kenkichi Sugiura⁹, Shinsuke Iida¹⁰ (1.Division of Hematology, Juntendo University School of Medicine, 2.Department of Hematology, Tochigi Cancer Center, 3.Department of Hematology, National Hospital Organization Mito Medical Center, 4.Department of Hematology Oncology, Cancer Institute Hospital of JFCR, 5.Department of Internal Medicine, Niigata Cancer Center Hospital, 6.Division of Hematology and Stem Cell Transplantation, Shizuoka Cancer Center, 7.Takeda Clinical Research and Development, Takeda Pharmaceutical Company Limited, 8.Oncology Therapeutic Area Unit, Takeda Pharmaceutical Company Limited, 9.Biostatistics, Japan Development Center, Takeda Pharmaceutical Company Limited, 10.Department of Hematology and Oncology, Nagoya City University)